+987.9%
MRNA vs CFG
+34.2%
+953.7%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | CFG | Excess | Alpha |
|---|---|---|---|---|
| 1D | +13.1% | +2.4% | +10.7% | +14.1% |
| 7D | +20.6% | +1.8% | +18.9% | +21.4% |
| 30D | +27.1% | +3.3% | +23.9% | +28.8% |
| 3M | +353.4% | -9.8% | +363.2% | +337.8% |
| 6M | +446.3% | +5.2% | +441.1% | +366.2% |
| YTD | +776.2% | +16.1% | +760.1% | +558.0% |
| 1Y | +987.9% | +33.7% | +954.2% | +639.8% |
| All | +987.9% | +34.2% | +953.7% | +639.8% |
Cumulative growth
Daily Returns
Daily percentage return beside CFG.
Daily Out/Under-Performance
Portfolio return minus CFG return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CFG return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded CFG wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling